✨ Medicine Distribution Consents




3492 NEW ZEALAND GAZETTE, No. 133 28 AUGUST 2008

Product: Ixempra
Active Ingredient: Ixabepilone 45mg
Dosage Forms: Powder for injection
Diluent

New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Baxter Oncology GmbH, Halle-Kunsebeck, Germany

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 22nd day of August 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6269

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Risperon
Active Ingredient: Risperidone 1mg/mL
Dosage Form: Oral solution

New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Dar Al Dawa Development & Investment Co. Limited. (DAD), Nau’r, Zabud & Sail Hisban, Nau’r, Jordan

Dated this 22nd day of August 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6267

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Antinaus (Restricted Medicine Pack)
Active Ingredient: Prochlorperazine maleate 5mg
Dosage Form: Tablet

New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India

Product: Antinaus (Prescription Medicine Pack)
Active Ingredient: Prochlorperazine maleate 5mg
Dosage Form: Tablet

New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India

Dated this 22nd day of August 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6268

New Zealand Public Health and Disability Act 2000

Appointments to the Quality Improvement Committee

Pursuant to section 11 of the New Zealand Public Health and Disability Act 2000, I appoint to the Quality Improvement Committee

Dr Cynthia Farquhar
as an "ex officio" member for a three-year term of office commencing on the date of this notification.

Dated at Wellington this 5th day of August 2008.

HON DAVID CUNLIFFE, Minister of Health.

go6166



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2008, No 133





✨ LLM interpretation of page content

πŸ₯ Provisional Consent to Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
22 August 2008
Medicine, Provisional Consent, Ixempra, Ixabepilone, Bristol-Myers Squibb
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to Distribution of New Medicine

πŸ₯ Health & Social Welfare
22 August 2008
Medicine, Consent, Risperon, Risperidone, Pacific Pharmaceuticals
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to Distribution of Changed Medicine

πŸ₯ Health & Social Welfare
22 August 2008
Medicine, Consent, Antinaus, Prochlorperazine maleate, Pacific Pharmaceuticals
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Appointments to the Quality Improvement Committee

πŸ₯ Health & Social Welfare
5 August 2008
Appointment, Quality Improvement Committee, Dr Cynthia Farquhar
  • Cynthia Farquhar (Dr), Appointed to Quality Improvement Committee

  • HON DAVID CUNLIFFE, Minister of Health